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Abstract
Background: Obesity and insulin dysregulation (ID) predispose horses to laminitis.
Determination of management practices or phenotypic markers associated with ID
may benefit animal welfare.
Objectives: Determine ID status of a population of Finnhorses using an oral sugar
test (OST) and compare phenotypes and management factors between ID and non-
ID Finnhorses.
Animals: One hundred twenty-eight purebred Finnhorses ≥3 years of age.
Methods: Owners were recruited using an online questionnaire regarding signalment,
history, feeding, and exercise of their horses. Selected contributing stables within a
predefined area were visited. Phenotypic markers of obesity and the weight of each horse
were recorded. After fasting overnight, horses received 0.45 mL/kg corn syrup
PO. Serum samples before and at 60 and 90 minutes after syrup administration were ana-
lyzed for insulin by chemiluminescent assay. Horses met ID criteria if insulin concentra-
tions were ≥33 μIU/mL at T0, ≥66 μIU/mL at T60 or T90 or some combination thereof.
Associations between phenotypic markers, feeding and exercise variables, and ID were
examined using mixed effects logistic regression modeling.
Results: Several phenotypic markers of obesity were significant on univariable analy-
sis but in the final multivariable model, only obesity (body condition score ≥8) was
associated with ID (P = .04). Over half of the horses (60% [95% confidence interval
(CI), 51%-68%]) were considered overweight or obese whereas 16% (95% CI, 10%-
23%) were classified as having ID.
Conclusions and Clinical Importance: Because obesity is associated with ID in cold-
blooded type horses, objective monitoring of phenotypic markers by owners may be
beneficial for health outcomes.
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1 | INTRODUCTION
Obesity is a major risk factor for insulin dysregulation (ID) and a substan-
tial health problem among equine populations worldwide.1,2,3 Insulin
dysregulation is defined as any combination of basal hyperinsulinemia,
postprandial hyperinsulinemia (in response to dynamic testing), or insulin
resistance,4 and is an important predisposing factor for laminitis, a pain-
ful hoof condition in horses that can lead to loss of use, chronic lame-
ness, and even death.5 Insulin dysregulation and generalized or regional
adiposity are features of equine metabolic syndrome (EMS) and can be
used as predictors of laminitis.6,7 Although not all obese animals have ID
(and vice versa), dynamic endocrine testing and appropriate weight man-
agement of overweight animals are recommended to decrease the pos-
sible risk for laminitis.6,8
Dynamic testing is the preferred method of determining ID in
horses and is more sensitive than basal testing alone.6 The oral sugar
test (OST) has been described in several studies9,10,11 as an ideal,
replicable method for dynamic ID testing at different doses
(0.15-0.45 mL/kg). It has been shown to be repeatable using binary
outcomes10 and is comparable to more invasive tests9; therefore, it is a
practical approach for on-farm testing.
Prevalence of ID in horses has been shown to vary from 18%
to 27% depending on the specified population.2,12,13 Breed differ-
ences in ID have been identified. For example, ponies and Andalu-
sian horses had significantly lower insulin sensitivity (IS) than did
Standardbred horses.14 Additionally, many of the published cases
of EMS have occurred in native British breeds. One study found
that cases of primary endocrinopathic laminitis (induced by ID with
or without pituitary pars intermedia dysfunction) were more likely
to occur in native British ponies compared to native Nordic ponies,
cold-, warm-, and hot-blooded horses.15 However, in another
study, cold-blooded type ponies had increased risk of laminitis
compared to warm-blooded type ponies.16 The ID status of certain
cold-blooded equine populations, such as Finnhorses, has not been
investigated.
The Finnhorse is a cold-blooded horse originating from Northern
European domestic horses. They are the only equine breed native to
Finland and have been bred as a pure breed since 1907, when the
studbook was founded. The registry recognizes 4 types of Finnhorse:
racing trotter, riding and pleasure, working, and pony-sized (www.
hippos.fi).
Factors associated with increased obesity risk include manage-
ment and exercise, primarily resulting from decreased physical activity
and excess energy intake, although genetic and epigenetic factors also
may play a role.17,18 In humans, physical activity has been shown to
improve IS, even in the absence of apparent weight loss.19 In studies
of horses, exercise has been shown to decrease serum concentrations
of inflammatory markers (serum amyloid A and haptoglobin)20 and
improve ID, particularly when exercise was of moderate intensity.21,22
In our study, we evaluated the ID status of a population of
Finnhorses in southern Finland by determining insulin response to
corn syrup OST. Our aim was to compare phenotypic markers of obe-
sity and management factors between ID and non-ID Finnhorses.
2 | MATERIALS AND METHODS
2.1 | Animals
The study protocol was approved by the National Animal Experimen-
tation Board of Finland (ESAVI/6728/04.10.07/2017). Horses met
study inclusion criteria if they were located within 150 km of Helsinki,
were ≥3 years old, and had no clinical evidence or history of systemic
inflammatory disease. A physical examination was performed on all
horses by a veterinarian and any animals with fever (≥38.5C), tachy-
cardia, tachypnea, signs of systemic inflammatory disease, or any
other potentially painful condition were excluded. An initial serum
biochemistry profile and a CBC were performed on each horse to
evaluate health status. Biochemical results were determined using a
commercial biochemistry analyzer (Konelab 30 Clinical Chemistry
Analyzer, ThermoFisher Scientific, Vantaa, Finland). The CBC was per-
formed using an ADVIA 212io hematology analyzer (Siemens,
Tarrytown, New York), and plasma fibrinogen concentration was
determined using a heat precipitation method.23 Any animal with
abnormal biochemical or CBC findings was excluded. Animals with
previously diagnosed pituitary pars intermedia dysfunction also were
excluded.
2.2 | Questionnaire
A link to a web-based questionnaire was advertised from September
to December in 2017 in the University of Helsinki Faculty of Veteri-
nary Medicine webpages seeking study enrollment by owners of
purebred Finnhorses ≥3 years of age living within approximately
150 km of Helsinki. The Veterinary Medicine webpages provided
owner resources and information about the hospital that were regu-
larly accessed by equine owners. The questionnaire requested infor-
mation about the signalment, history, feeding, exercise and previous
and current diseases of each horse. Additionally, owners were asked
to estimate their horse's body condition score (BCS, Henneke 1-9
scoring system)24 and cresty neck score (CNS, Carter 0-5 scoring sys-
tem)25 with the help of illustrative figures. With regard to exercise,
owners were asked to report their horse's main use (racing, draft, rid-
ing competition, pleasure riding, pet, breeding), estimate how many
days per week on average they exercised their horse, how many days
per week the horse was sweating during exercise, and how many
hours per week the horse was exercised at walk, trot, and canter.
Horses were grouped into either intense use (racing, draft, competi-
tion) or nonintense use (pleasure riding, pet, breeding). The hours per
week spent trotting and cantering (trot + canter) were added together
as a single analysis value. Cumulative exercise was calculated by
adding walk, trot, and canter hours per week. Finally, the owners
were asked to report the amount of roughage (kg) and concentrate
(kg) their horse received each day. Concentrate was defined as any
feed (commercially prepared or otherwise) given to the horse that was
not a vitamin or mineral supplement or both or type of roughage. If
owners reported a range, the upper limit value was used for analysis.
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2.3 | Sample size
A convenience sample of recruited horses that were ≥3 years old
were selected for a stable visit based on their geographical location
(within 150 km of the institution). Before the start of testing, sample
size was calculated using the online Epitools sample size calculator26.
Given the population size of approximately 20 000 Finnhorses, an
expected incidence of 15% to 20%, a confidence interval (CI) of 95%,
and a power of 80%, the calculated sample size was 150. Operations
housing ≥5 Finnhorses initially were selected but premises with <5
horses later were included. All available horses at each stable that met
inclusion criteria had OST performed.
2.4 | Physical measurements
One of 2 trained veterinarians (Justin R Box, Ninja P Karikoski) per-
formed the physical measurements, including phenotypic markers of
obesity and hoof wall changes. Phenotypic markers of obesity
included BCS, CNS, and supraorbital fat pads. Assessment of macro-
scopic hoof wall changes that were indicative of laminitis included
divergent growth rings, white line separation, and dropped soles.
The following physical measurements were obtained using
a weight tape designed for horses (Virbac Animal Health):
weight, heart-girth, widest part of the abdomen, and neck circum-
ference (midpoint of the neck). Additionally, BCS and CNS
were assessed.24,25 Horses with BCS of 7 were considered over-
conditioned3 and classified as obese if their BCS was ≥8. Horses
were considered to have a cresty neck if CNS was ≥3. Supraor-
bital fat pads were graded on a scale of 0-3; 0 being deep/
concave and 3 being rounded/convex.
2.5 | Basal blood samples
Basal blood glucose concentrations were determined using lithium-
heparin blood (Vacuette LH, Greiner Bio-One, Kremsmünster, Austria)
immediately after sampling using a handheld veterinary glucometer
(AlphaTRAK II, Zoetis, North Chicago, Illinois).
Blood for adrenocorticotropic hormone (ACTH) concentration
measurement was collected in 6-mL EDTA tubes (Vacuette K2EDTA,
Greiner Bio-One, Kremsmünster, Austria) and kept cool until centrifu-
gation (within 8 hours). The separated plasma was frozen and stored
at −80C until shipment on dry ice to the diagnostic laboratory. Ana-
lyses were performed in duplicate using a chemiluminescent immuno-
assay (Immulite 2000 XPi, The Philip Leverhulme Equine Hospital,
Liverpool, UK). All animals with seasonally increased basal plasma
ACTH concentrations were excluded from the study. The seasonally
adjusted ACTH cutoff concentrations used for the study were
89.4 pg/mL for horses sampled in October and 35.2 pg/mL for horses
sampled in November and December (Adams A., Abstract, Interna-
tional Equine Endocrinology Summit, 2017).
2.6 | Oral sugar test
Oral sugar tests were performed either at the stables (n = 139) or in the
University of Helsinki (n = 5) during a period from the last week of
October 2017 through the second week of December 2017. The eve-
ning before the test, the horses were stalled and allowed to have a slice
of dry hay or haylage (1-2 kg) no later than 22:00. No grain or additional
hay was allowed until after the OST was completed. All horses had
access to water throughout the entire experiment. The OSTs were per-
formed in the morning between 06:00 and 10:00. Horses were given
0.45 mL/kg body weight (BW) corn syrup PO (Karo Light, ACH Food
Companies Inc, Cordova, TN) via 100-ml dosing syringes. Karo Light con-
tains, on average, 158 mg/mL of maltose and 198 mg/mL glucose, so -
that horses received a combined maltose and glucose dose of
160.3 mg/kg BW.11 For insulin concentration measurement, blood was
collected into 6- mL serum tubes (Vacuette, Z serum clot activator,
Greiner Bio-One, Kremsmünster, Austria) before syrup administration
and at 60 (T60) and 90 (T90) minutes thereafter. Blood was allowed to
clot at ambient temperature for at least 60 minutes. Subsequently, all
samples were centrifuged, serum separated within 8 hours, and stored at
−80C until shipment on dry ice to the laboratory for analysis. All sam-
ples were measured in duplicate using a chemiluminescent immunoassay
(Immulite 2000 XPi, The Philip Leverhulme Equine Hospital, Liverpool,
United Kingdom). The reportable range for the Immulite 2000XPi was
2-300 μIU/mL. Our preliminary correlation studies have shown excellent
correlation (r = .996) between the Immulite 2000XPi and the more com-
monly used Immulite 2000 (Carslake, H., unpublished data), but the
2000XPi reports consistently higher values than the 2000. Therefore, a
higher cutoff concentration of 66 μIU/mL was used for our study
instead of the suggested 40 μIU/mL. Horses were categorized as having
ID based on insulin concentrations ≥33 μIU/mL at T0 or ≥66 μIU/mL at
either T60 or T90 or both.
2.7 | Statistical analysis
The area under the curve (AUC) was calculated for the insulin
response (T0-T90) using the trapezoidal method. The normality of
each variable distribution was tested using the Shapiro-Wilk test.
Correlations among BCS, glucose, and insulin were tested using
Spearman rank correlation with Bonferroni correction. Comparison of
owner versus investigator BCS and CNS was performed using related
samples Friedman's 2-way analysis of variance by ranks.
To assess the effect of different covariates on ID, mixed effects
logistic regression models, modeling the odds for occurrence of ID,
were fitted. First, each covariate was separately modeled with the
response, the model including ID status as a response, covariate as a
fixed effect and cluster (stable) as a random effect (univariable analy-
sis). Variables with P value <.2 were taken forward to multivariable
analyses. Similar mixed effects logistic regression models as for the
individual analyses were fitted. In all models, odds ratios (OR) for com-
parisons between groups for categorical covariates or increase of
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1 unit in continuous or ordinal covariates with 95% CI and P values
were estimated using contrasts from the same model. P values <.05
were considered statistically significant. Statistical analyses were per-
formed at 4Pharma Ltd using SAS System for Windows, version 9.4
(SAS Institute Inc., Cary, North Carolina).
3 | RESULTS
Two hundred thirty-three owners completed the online questionnaire,
representing 291 horses. One hundred forty-four horses from 30 pre-
mises were selected for detailed examination and testing. Of the
144 horses sampled, 1 horse was excluded because of increased body
temperature and 15 were excluded because of seasonally increased
basal plasma ACTH concentrations. The remaining 128 horses con-
sisted of 63 geldings (49%), 58 mares (45%), and 7 stallions (5%).
Owners categorized the use of their horses in the following manner:
106 as “pleasure riding” horses, 7 as “riding competition” horses, 2 as
“breeding” horses, 10 as “racehorses,” 2 as a “pet,” and 1 as a “draft
horse.” Therefore, 18 horses were considered as experiencing intense
use and 110 nonintense use.
The phenotypic marker results of the 128 horses are presented
in Table 1. There were 77/128 (60%; 95% CI, 51%-68%) over-
conditioned or obese horses, of which 35/128 (27%; 95% CI, 20%-
36%) were overconditioned and 42/128 (33%; 95% CI, 25%-41%)
were obese. The BCS given by the owners were significantly lower
than the BCS given by the investigator (P < .001). The CNS given by
the owners, however, were significantly higher than those given by
the investigator (P < .001). Forty-two horses (33%; 95% CI, 25%-
41%) were considered to have a cresty neck. Seventy-three (57%;
95% CI, 48%-65%) horses had visible growth rings on ≥1 hooves,
but none of the horses had divergent hoof rings, white line separa-
tion, or dropped soles indicative of a history of laminitis. Six horses
had a history of laminitis diagnosed by a veterinarian and 2 addi-
tional horses had historical owner-suspected but not veterinarian-
confirmed laminitis.
3.1 | Oral sugar test
No adverse events were noticed by the investigators during the OST or
reported by the owners after the study. All but 1 of the horses readily
accepted the PO dosing of the syrup. The 1 horse that refused the dos-
ing syringe consumed all of the syrup (within 1-2 minutes) after the
entire volume was ejected into the horse's empty food bucket. In total,
20/128 (16%; 95% CI, 10%-23%) horses met the criteria for ID
(Table 2). Of these, only 1 animal had increased insulin concentration at
T0, 9 at T60, and 19 at T90. Eight horses had increased insulin concen-
trations at both T60 and T90. Seven of the 8 horses with owner-
reported history of laminitis were categorized in the ID group.
Body condition scores correlated significantly with insulin T0
(ρ = .253, P = .04), T60 (ρ = .309, P < .01), T90 (ρ = .270, P = .02), and
AUC (ρ = .305, P < .01). Basal glucose concentration correlated signifi-
cantly with insulin T60 (ρ = .267, P = .03) and AUC (ρ = .261, P = .03).
No other significant correlations were detected among BCS, glucose,
and insulin.
Of the 42 obese horses, only 11 (26%; 95% CI, 15%-41%) met
ID criteria, and of the 35 overconditioned horses, only 4 (11%; 95%
CI, 5%-26%) met ID criteria. Five (4%; 95% CI, 2%-9%) non-
overconditioned or obese horses were categorized as having ID.
Several variables were found to be significant in univariable analy-
sis (Table 3) and these were moved forward into a multivariable
model. However, because several significant obesity-related variables
were found in univariable analysis that correlated with each other, the
variables that were not affected by the horse's height (BCS, CNS, and
obesity versus heart-girth, weight, widest part of abdomen) were
selected for multivariable analysis. Each of the obesity variables
was analyzed separately in a multivariate model with the other
4 (age, sex, glucose, combined trot and canter hours/week) variables
(3 separate models). Finally, only obesity (BCS ≥ 8) was shown to be
associated with ID in multivariable models (OR, 3.29; 95% CI, 1.04%-
10.37%; P = .04).
TABLE 1 Descriptive data of phenotypic markers, endocrine
values and management factors reported by the equine owner,
investigator or both in insulin dysregulated (ID, n = 20) and non-ID
(n = 108) Finnhorses
Variable
Non-ID
(n = 108) ID (n = 20)
Age (y) 9.0 (5-13) 12.0 (7.25-16)
BCS investigator (1–9) 7.0 (6-7.5) 8.0 (6.25-8)
BCS owner (1–9) 6.0 (5-7) 7.0 (6-7)
Body weight (kg) 553 (504-601) 585 (541-626)
CNS researcher (0-5) 2.0 (1-3) 2.5 (2-3)
CNS owner (0-5) 2.0 (2-3) 3.0 (2-3)
Supraorbital fat (0-3) 1.0 (0-1) 1.0 (1-1.5)
Heart-girth (cm) 190 (184-196) 195 (190-199)
Widest part of abdomen (cm) 214 (205-222) 218 (213-225)
Neck circumference (cm) 110 (104-114) 110 (104-115)
Triglycerides (mmol/L) 0.23 (0.19-0.27) 0.25 (0.17-0.34)
Basal glucose concentration
(mmol/L)
6.0 (5.5-6.4) 6.4 (6.1-6.7)
Amount of roughage
(g/kg BW)
19.7 (15.7-23.9) 18.2 (16.8-21.6)
Amount of concentrates/grain
(g/kg BW)
8.43 (.0-18.1) 7.35 (1.08-19.1)
Exercise (d/wk) 5.0 (3.0-5.0) 5.0 (3.0-5.0)
Sweating during exercise
(d/wk)
3.0 (1.0-3.0) 1.0 (1.0-3.0)
Trot + canter (h/wk) 3.0 (1.0-4.0) 2.0 (.25-2.75)
Cumulative exercise (h/wk) 5.0 (3.0-6.0) 3.5 (2.25-4.75)
Note: Values are reported as median and (interquartile range).
Abbreviations: BCS, body condition score; CNS, cresty neck score.
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4 | DISCUSSION
In this population of Finnhorses in southern Finland tested between
October and December in 2017, obesity was the only variable associ-
ated with ID in multivariable analysis. The risk for ID was 3.29 times
higher in horses with BCS ≥8 than in horses with lower BCS. In addi-
tion, several phenotypic markers related to obesity (BCS, CNS, BW,
heart-girth, widest part of the abdomen) were found to be significant
on univariable analysis. However, variables associated with feeding or
exercise were not significant risk factors in this Finnhorse population.
Small sample size could be a reason for the lack of association with
these variables, with the majority of horses being overconditioned or
obese and not undergoing intense exercise.
Not all obese or overconditioned horses had ID. In fact, most of
the obese or overconditioned horses (81%) did not have
ID. Supraorbital fat pad and neck circumference were not significant
risk factors in univariable analysis. In 2 previous studies, ponies with
ID (basal hyperinsulinemia) did not have significantly higher BCS
or CNS than did ponies with normal insulin concentrations, and
therefore the authors suggested that assessment of physical obesity
parameters might not be an accurate predictor for ID in native pony
breeds.8,12 However, the majority of ponies in these studies were
overconditioned or obese, which may have affected the results. In
another more heterogenous group of ponies, CNS was positively
associated with postprandial insulin concentration (oral glucose test),
and ponies with a cresty neck had 5 times higher risk of having ID
than did ponies with a normal neck.7 In addition, in a mixed equine
population in the US, overconditioned and obese horses had signifi-
cantly higher basal plasma insulin concentrations (indicative of ID)
compared to optimally conditioned horses.13 Additionally, that study
found breed differences in IS and insulin concentrations. Therefore,
the association between ID and obesity indeed may be breed-related,
and this possibility should be taken into consideration when evaluat-
ing the status of and risks for ID in an individual horse.
Exercise was not shown to be a protective factor for ID in our
study. However, none of the animals registered as trotting racehorses
(n = 10) met the criteria of ID or had a history of laminitis, nor were any
of them obese. Previously published studies indicate that moderate-
intensity, short-term (45 min/d for 7 days)21 and long-term (60 min/d
for 1 month)27 training have been shown to improve ID in horses. Addi-
tionally, a recent study showed that ID was significantly improved by
diet modification and low-intensity exercise when compared with diet
modification alone.28 The study also found that low-intensity exercise
without diet change was insufficient to improve IS despite decreases in
total body fat mass. Another study demonstrated that even long-term
low-intensity exercise, such as walking 2 hours twice daily for 3 months,
did not improve IS although the animals lost weight during the research
period.29 Therefore, light exercise alone, even if done regularly several
hours per week, may not be sufficient to protect horses from
ID. Accuracy in owner reporting may have been a factor in the non-
significance of exercise data in our study. The questionnaire was
designed to be as straightforward as possible, but some owners'
TABLE 2 Group-wise comparison of insulin values T0, T60, T90, and area under the curve (AUC) divided into insulin dysregulated (ID) and
non-ID in response to an oral sugar test
Variable All (n = 128) Non-ID (n = 108) ID (n = 20) Range all (n = 128)
Insulin T0 (μIU/mL) <2.0 (<2.0) <2.0 (<2.0) <2.0 (<2.0-6.6) <2.0-35.4
Insulin T60 (μIU/mL) 11.4 (5.6-28.8) 9.4 (5.2-17.6) 59.1 (43.2-79.6) <2.0-254.5
Insulin T90 (μIU/mL) 14.0 (7.9-40.8) 11.4 (6.9-20.8) 87.0 (73.1-114.6) <2.0-446.5
Insulin AUC 771 (381-1847) 609 (368-1097) 4017 (3324-5002) 0-19 211
Note: Values reported are the median and interquartile range.
TABLE 3 Results of univariable mixed effects logistic regression
analysis of signalment, morphometric and metabolic variables in 128
Finnhorses accounting for clustering at stable level
Variable
Odds
ratio 95% CI
P
value
Age (y) 1.07 0.98-1.17 .15
Sex (female versus male) 2.13 0.74-6.10 .16
Usage (nonintense versus
intense)
3.77 0.42-33.55 .23
BCS 1–9 (1 unit) 2.11 1.18-3.77 .01
Obesity (yes/no) 4.24 1.45-12.37 .009
CNS 0–5 (1 unit) 1.96 1.07-3.59 .03
Cresty neck (yes/no) 2.95 0.99-8.33 .05
Supraorbital fat (1 unit) 1.51 0.73-3.13 .27
Weight (kg) 1.01 1.00-1.02 .04
Widest part of abdomen (cm) 1.05 1.00-1.10 .05
Heart-girth (cm) 1.08 1.01-1.16 .03
Neck circumference (cm) 1.03 0.97-1.09 .41
Basal glucose (mmol/L) 2.00 0.94-4.25 .07
Triglycerides (mmol/L) 1.47 0.74-2.95 .27
Amount of concentrates/grain
(g/kg BW)
0.07 0.00-8.35 .27
Amount of roughage (g/kg BW) 0.48 0.15-1.55 .22
Exercise (d/wk) 1.08 0.77-1.51 .67
Sweating during exercise (d/wk) 0.83 0.56-1.23 .36
Trot + canter (h/wk) 0.75 0.53-1.04 .08
Cumulative exercise (h/wk) 0.90 0.73-1.11 .31
Note: Significant results are shown in bold.
Abbreviations: BCS, body condition score; CNS, cresty neck score.
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perceptions regarding health, nutrition and exercise intensity may not
have been realistic, as has been shown in some previous studies.30,31
Owners underestimated their horses' BCS by 1 grade compared
to the investigators, in agreement with previous study reports,2,32,33
which is relevant when assessing weight management of horses.
Because BW, heart-girth and widest part of the abdomen were taken
with a standard, commercially available weight and measuring tape
designed for horses, owners can record and track measurements of
their horses without the need of a veterinarian or expensive equip-
ment. Use of this tool allows owners of horses with ID to identify
horses at risk, or monitor treatment success, such as diet changes.
Weight tapes have been shown to overestimate weight of horses34,35
and therefore, the animals in our study may have been marginally ligh-
ter, on average, than what is presented in Table 1. However, change
in BW is what often dictates owner management, not actual weight.
Therefore, especially where weighbridge scales are unavailable, use of
a weight tape, as employed in our study, represents a practical moni-
toring tool compatible with typical field conditions.
The frequency of ID in this population of Finnhorses was 16%,
which is close to previously published reports of 18% to 27% in other
breeds.12,13 Despite phenotypic markers of obesity being significantly
higher in the ID group, the frequency of ID was low compared to
the percentage of overconditioned or obese Finnhorses (60%). This
observation supports previous findings of a lower breed representa-
tion of laminitis in this breed.14 Arbitrarily decreasing the cutoff to
50 μIU/mL increased the number of horses with ID to 24 (19%; 95%
CI, 13%-26%). This possibly could be a more sensitive cutoff for sam-
ples analyzed using the Immulite 2000XPi.
Fasting or resting blood glucose measurement is not a useful
diagnostic test to determine ID. Instead, it should be used as part of a
comprehensive diagnostic plan.6 Although fasting blood glucose con-
centration was a risk factor for ID in univariable analysis, the concen-
trations of all horses were within the normal reference range.
We used a higher corn syrup dose (0.45 mL/kg), which has been
suggested to have higher sensitivity for ID than the previously used
lower doses.11 However, the data originates from a study in which
the purpose was to differentiate previously laminitic and nonlaminitic
ponies from each other, not to find ID animals in a random popula-
tion.11 Therefore, this higher dose may be suboptimal, and more
research is warranted in this area.
5 | CONCLUSIONS
In this sample population of Finnhorses, obesity was shown to be
associated with ID. Several phenotypic indicators of obesity were
found to be significantly higher in horses with ID in univariable analy-
sis, suggesting that generalized obesity is associated with ID in cold-
blooded type horses. The frequency of ID in this population when
tested using 0.45 mL/kg OST was 16%. Because owners were found
to underestimate the BCS of their horses, they should be encouraged
to regularly measure and record BCS and weight estimates to track
changes over time.
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